Tuesday, December 9, 2025

Transforming Chronic Back Pain Treatment: Dr. Roger H. Coletti Presents the CMECD® Breakthrough

The upcoming International Conference on Addiction Medicine, Mental Health and Psychiatry (ICAMP 2026)—scheduled for March 23–25, 2026 as a hybrid event in Singapore & Online—will showcase a compelling virtual presentation by Dr. Roger H. Coletti of Interventional Health, USA.

His talk introduces an innovative, procedure-based approach aimed at reducing, and often eliminating, chronic opioid use among patients suffering from long-standing back pain.


🔍 A New Perspective on Chronic Back Pain and Opioid Dependence

Chronic back pain remains one of the leading drivers behind long-term opioid prescriptions. Even patients who undergo back surgery often continue to experience persistent pain, commonly diagnosed as Post Laminectomy Syndrome, affecting up to 40% of patients.

Dr. Coletti’s work challenges conventional assumptions by focusing on chronic muscle spasm as a central cause of pain—offering new hope for opioid-free management.

🩺 Presentation Title

Putting an End to Chronic Opioid Use for Chronic Back Pain with the CMECD® Procedure


🌟 Highlights of Dr. Coletti’s Presentation

·         Chronic muscle spasm is identified as a primary source of ongoing back pain, even in post-surgical patients.

·         The CMECD® procedure, developed and refined over 15 years, offers a unique and targeted solution.

·         EMG technology is used to identify spontaneous electrical activity (SEA) in muscles that remain locked in chronic spasm.

·         Targeted injections of a phenoxybenzamine, lidocaine, and dexamethasone mixture deactivate SEA and release the spasm.

·         Phenoxybenzamine’s covalent receptor binding results in long-lasting effects, typically spanning 2–3 months.

·         Patients often report immediate relief, with many reducing or stopping opioid use altogether.

·         Clinical surveys confirm statistically significant improvements in long-term pain outcomes.

·         Duration of chronicity does not influence success—muscles in spasm for over 20 years can respond just as well as recent pain cases.

·         The medication used is FDA-approved and can be prepared by any sterile compounding pharmacy.

·         More educational material is available at CMECD.info, offering guidance for practitioners.


👨⚕️ Meet the Speaker: Dr. Roger H. Coletti

Dr. Coletti’s distinguished academic and clinical background includes:

·         BA – Georgetown University

·         MA – Hofstra University

·         MD – State University of New York at Downstate

·         Internship & Residency – Nassau County Medical Center

·         Fellowships in Cardiology and Interventional Cardiology at Columbia Presbyterian Medical Center and Westchester County Medical Center

·         Honors: FACC, FASNC, FSCAI

His current clinical interests focus on chronic muscle spasm and pain, where he continues to drive meaningful innovations.


📅 Event Information

Event: International Conference on Addiction Medicine, Mental Health and Psychiatry (ICAMP 2026)
Dates: March 23–25, 2026
Format: Hybrid (Singapore + Online)
Website:
https://addiction.miconferences.com/
Email: addiction@mathewsconference.com
Phone: +1 (312) 462-4448
WhatsApp: +1 (424) 377 0967
Abstract Submission:
https://addiction.miconferences.com/abstract-submission
Registration:
https://addiction.miconferences.com/register
X Profile:
https://x.com/ICAMPevent


#ICAMP2026 #AddictionMedicine #BackPainTreatment #CMECDProcedure #OpioidReduction #PainManagement #ChronicPainRelief #MedicalInnovation #MentalHealthConference #SingaporeEvents #HybridMedicalConference #InterventionalHealth #OpioidAlternatives

No comments:

Post a Comment